GB201615560D0 - Novel compounds and therapeutic uses thereof - Google Patents

Novel compounds and therapeutic uses thereof

Info

Publication number
GB201615560D0
GB201615560D0 GBGB1615560.8A GB201615560A GB201615560D0 GB 201615560 D0 GB201615560 D0 GB 201615560D0 GB 201615560 A GB201615560 A GB 201615560A GB 201615560 D0 GB201615560 D0 GB 201615560D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
therapeutic uses
therapeutic
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1615560.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centauri Therapeutics Ltd
Original Assignee
Centauri Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centauri Therapeutics Ltd filed Critical Centauri Therapeutics Ltd
Priority to GBGB1615560.8A priority Critical patent/GB201615560D0/en
Publication of GB201615560D0 publication Critical patent/GB201615560D0/en
Priority to PCT/GB2017/052699 priority patent/WO2018051085A1/en
Priority to AU2017328896A priority patent/AU2017328896A1/en
Priority to BR112019004877A priority patent/BR112019004877A2/en
Priority to CA3036405A priority patent/CA3036405A1/en
Priority to DK17771531.5T priority patent/DK3512544T3/en
Priority to CN201780069622.1A priority patent/CN110022896B/en
Priority to EP17771531.5A priority patent/EP3512544B1/en
Priority to ES17771531T priority patent/ES2854991T3/en
Priority to JP2019513946A priority patent/JP7185622B2/en
Priority to US16/333,219 priority patent/US11014966B2/en
Priority to MX2019002879A priority patent/MX2019002879A/en
Priority to KR1020197010569A priority patent/KR102544465B1/en
Priority to ZA201901422A priority patent/ZA201901422B/en
Priority to IL265269A priority patent/IL265269B/en
Priority to JP2022143727A priority patent/JP2022184922A/en
Ceased legal-status Critical Current

Links

GBGB1615560.8A 2016-09-13 2016-09-13 Novel compounds and therapeutic uses thereof Ceased GB201615560D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1615560.8A GB201615560D0 (en) 2016-09-13 2016-09-13 Novel compounds and therapeutic uses thereof
KR1020197010569A KR102544465B1 (en) 2016-09-13 2017-09-13 New compounds and their therapeutic uses
CN201780069622.1A CN110022896B (en) 2016-09-13 2017-09-13 Novel compounds and therapeutic uses thereof
ES17771531T ES2854991T3 (en) 2016-09-13 2017-09-13 Peptide compounds and therapeutic uses thereof
BR112019004877A BR112019004877A2 (en) 2016-09-13 2017-09-13 new compounds and therapeutic uses thereof
CA3036405A CA3036405A1 (en) 2016-09-13 2017-09-13 Novel compounds and therapeutic uses thereof
DK17771531.5T DK3512544T3 (en) 2016-09-13 2017-09-13 PEPTIDE COMPOUNDS AND THERAPEUTIC USES THEREOF
PCT/GB2017/052699 WO2018051085A1 (en) 2016-09-13 2017-09-13 Novel compounds and therapeutic uses thereof
EP17771531.5A EP3512544B1 (en) 2016-09-13 2017-09-13 Peptide compounds and therapeutic uses thereof
AU2017328896A AU2017328896A1 (en) 2016-09-13 2017-09-13 Novel compounds and therapeutic uses thereof
JP2019513946A JP7185622B2 (en) 2016-09-13 2017-09-13 NOVEL COMPOUNDS AND THERAPEUTIC USE THEREOF
US16/333,219 US11014966B2 (en) 2016-09-13 2017-09-13 Compounds and therapeutics uses thereof
MX2019002879A MX2019002879A (en) 2016-09-13 2017-09-13 Novel compounds and therapeutic uses thereof.
ZA201901422A ZA201901422B (en) 2016-09-13 2019-03-07 Novel compounds and therapeutic uses thereof
IL265269A IL265269B (en) 2016-09-13 2019-03-11 Novel compounds and therapeutic uses thereof
JP2022143727A JP2022184922A (en) 2016-09-13 2022-09-09 Novel compound and therapeutic use of the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1615560.8A GB201615560D0 (en) 2016-09-13 2016-09-13 Novel compounds and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
GB201615560D0 true GB201615560D0 (en) 2016-10-26

Family

ID=57234447

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1615560.8A Ceased GB201615560D0 (en) 2016-09-13 2016-09-13 Novel compounds and therapeutic uses thereof

Country Status (1)

Country Link
GB (1) GB201615560D0 (en)

Similar Documents

Publication Publication Date Title
HK1247614A1 (en) Therapeutic compounds and uses thereof
HK1243073A1 (en) Therapeutic compounds and uses thereof
HK1248697A1 (en) Therapeutic compounds and uses thereof
ZA201802256B (en) Compounds and therapeutic uses thereof
HK1257539A1 (en) Novel compounds and uses thereof
GB201617064D0 (en) Compounds and their therapeutic use
HK1258727A1 (en) Therapeutic compounds
GB201608797D0 (en) Therapeutic use
IL265269B (en) Novel compounds and therapeutic uses thereof
IL270011B (en) Therapeutic compounds and methods
GB201418809D0 (en) Therapeutic agents and uses thereof
GB201617339D0 (en) Therapeutic compounds
GB201616839D0 (en) Therapeutic compounds
GB201617470D0 (en) Novel therapy
GB201600376D0 (en) Novel therapeutic agents
IL263821A (en) Therapeutic compounds
IL257737B (en) Methanopyrrolo-pyridine-carboxylate based therapeutic compounds and synthesis thereof
GB201614224D0 (en) Compounds and uses thereof
IL270460B1 (en) Novel compounds and therapeutic uses thereof
GB201615560D0 (en) Novel compounds and therapeutic uses thereof
GB201707076D0 (en) Novel compounds and therapeutic uses thereof
GB201705681D0 (en) Novel compounds and therapeutic uses thereof
GB201705678D0 (en) Novel compounds and therapeutic uses thereof
GB201705682D0 (en) Novel compounds and therapeutic uses thereof
GB201705683D0 (en) Novel compounds and therapeutic uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)